AAD: Thalidomide Safe Second-Line Therapy for Cutaneous Lupus Erythematosus : Skin & Allergy News

Links shared publicly online about this topic.

501
total visits

AAD: Thalidomide Safe Second-Line Therapy for Cutaneous Lupus Erythematosus : Skin & Allergy News

Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s

View full resource at skinandallergynews.com

Tags: Allergies, Skin, Leprosy Medication, Lupus, Thalomid, Thalidomide, Safety